NDC 63323-130-41 - DOXY 100(TM) DOXYCYCLINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-130
- Requested NDC
- 63323-130-41
- Package NDCs from labels
- 63323-130-03, 63323-130-13, 63323-130-41, 63323-130-17, 63323-130-02, 63323-130-11
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DOXY 100(TM) DOXYCYCLINE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxy 100 - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2021-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxy 100 - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2021-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxy 100 - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2020-06-04 | HUMAN PRESCRIPTION DRUG LABEL |
| Doxy 100 - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2020-02-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-130-02 | Doxy 100 | 10 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 10 | 8 | |
| 63323-130-11 | Doxy 100 | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 8 | |
| 63323-130-03 | Doxy 100 | 10 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 10 | 5 | |
| 63323-130-13 | Doxy 100 | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 5 | |
| 63323-130-17 | Doxy 100 | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 3 | |
| 63323-130-41 | Doxy 100 | 10 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-130 | DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 8 | Current NDC, Legacy NDC, 2 package rows | 20200610_b0894010-39bd-459f-8563-cf83343105ee.zip |
| 63323-130 | DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 5 | Current NDC, Legacy NDC, 2 package rows | 20210312_b256babb-1bba-4b0c-8837-d13ba3af7659.zip |
| 63323-130 | DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ] | 3 | Current NDC, Legacy NDC, 2 package rows | 20210204_a7b754e2-a028-469d-ba95-8412ef03ab0a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-130-02 | EA - Each | 63323-130 | edc7cbba-452b-471d-8d2b-4a2a363804bd | 1 | 2021-08-05 |
| 63323-130-03 | EA - Each | 63323-130 | a20d17a4-29c2-4d0e-9ea1-581bd979c321 | 1 | 2021-09-07 |
| 63323-130-11 | EA - Each | 63323-130 | 48113d52-439a-4a9f-b934-26c54770a14a | 1 | 2013-02-13 |
| 63323-130-13 | EA - Each | 63323-130 | 7698ad16-4f9a-4a8a-a05b-b70c7a026c53 | 1 | 2013-09-04 |
| 63323-130-17 | EA - Each | 63323-130 | 9f82722c-19ff-46b8-9323-dabe43b13861 | 1 | 2014-12-01 |
| 63323-130-41 | EA - Each | 63323-130 | 8403a847-92ed-40b5-ad20-d703f943c9e2 | 1 | 2022-01-06 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| doxycycline | DOXYCYCLINE | Preferred Pharmaceuticals Inc. | bcc95094-80ed-4023-b2a6-955a4810bfbe | 2026-07-30 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | cf95b2ca-2cf8-49a8-8e3a-f9b0f5b2072c | 2026-07-29 | Warnings, Adverse reactions | 19XTS3T51U |
| PRENATE Restore | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, BIOTIN, CALCIUM CARBONATE, FERROUS FUMARATE, MAGNESIUM OXIDE, LACTIC ACID AND DOCONEXENT | Avion Pharmaceuticals, LLC | 1076ba9a-0168-492f-ba9b-99fa02186092 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | PQ6CK8PD0R |
| PNV-DHA | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM, FERROUS FUMARATE, MAGNESIUM, DOCONEXENT | Acella Pharmaceuticals, LLC | 038fe2e7-dc16-485c-b5fb-746db7231347 | 2026-07-23 | Boxed warning, Adverse reactions | PQ6CK8PD0R |
| PNV-Omega | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CORBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM, DOCONEXENT, ICOSAPENT | Acella Pharmaceuticals, LLC | 735c5531-137f-4cee-8c68-ae121045a8ff | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | PQ6CK8PD0R |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | 3af9348c-a98b-4059-a5ef-4229e2b33af0 | 2026-07-20 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | 0994d23a-f9e4-4c33-ba44-a1f4ae4a312c | 2026-07-20 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | 1401d590-0967-4c6b-b52b-a83e9f6df097 | 2026-07-17 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | b988f851-cc06-4570-9706-cf65d370bd8e | 2026-07-17 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | PD-Rx Pharmaceuticals, Inc. | 35aa295e-ff1b-453b-8eeb-65bbeda3baa5 | 2026-07-17 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycyclate Hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 4dc319c1-b7ef-40e4-9e66-fb24cfdefea8 | 2026-07-09 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 6e3d0691-c071-441c-9b00-22a380305066 | 2026-07-03 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Chartwell RX, LLC | fad03768-f1d2-459f-965e-0ec29f189f1f | 2026-06-30 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Strides Pharma Science Limited | 2deeee4f-b342-a178-e063-6394a90af897 | 2026-06-26 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Strides Pharma Science Limited | b8b76aaa-575b-497f-b854-c42bc992c784 | 2026-06-26 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | St. Mary's Medical Park Pharmacy | 02f87c60-8425-1a1e-e063-6294a90a0c94 | 2026-06-25 | Warnings, Adverse reactions | 19XTS3T51U |
| Minovia Mini | MINOVIA MINI | Oncora Pharma, LLC | 297673c1-23db-47b5-8cfb-aaecc0790838 | 2026-06-24 | Warnings, Adverse reactions | PQ6CK8PD0R |
| MCAS Support | APIS MELLIFICA, ANTIMONIUM CRUDUM, ASCORBICUM ACIDUM, BOVISTA, CARBOLICUM ACIDUM, CHAMOMILLA, CORTISONE ACETICUM, GINKGO BILOBA, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, NATRUM MURIATICUM, QUERCETIN, RHUS TOX, SCUTELLARIA LATERIFLORA, STOMACH (SUIS), URTICA URENS | Deseret Biologicals, Inc. | af3d5f8f-6f24-4045-8730-c776ff54bcc4 | 2026-06-24 | Warnings | PQ6CK8PD0R |
| Boostervite | MULTIVITAMIN | PureTek Corporation | 53efbf65-8844-8486-e063-6394a90a51d3 | 2026-06-18 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Unit Dose Solutions, Inc. | 548d4218-2feb-8716-e063-6394a90afbe3 | 2026-06-18 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.